Cartilage Inc.

Irvine, CA

UEI
C47HFKTMNMA4
CAGE
89M68
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
cartilage.tech
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

Vendor Location Primary NAICS
Cytex Ortho UEI G9RMDCWJYGL3 Durham, NC —
WNT Scientific LLC UEI CZVHJRF9T6H3 Rochester, NY 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Ortholevo, Inc. UEI P3HTBAK4HNC4 Lynnfield, MA 325412 Pharmaceutical Preparation Manufacturing
Insoma Bio, Inc. UEI LF3PGT7RN6G7 Durham, NC —
Theradaptive Inc. UEI DN45N68LM8M6 Frederick, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)

About the company

Cartilage Inc. is a leading biotech company dedicated to developing innovative solutions for cartilage regeneration. Its mission is to revolutionize the treatment of cartilage damage and osteoarthritis by providing effective and long-lasting therapies. Cartilage Inc. is a for-profit organization based in the United States.

Cartilage Inc. has received several federal grant awards to support its work in developing cartilage repair products and technologies. In 2023, the company received a $252,127 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to develop Chondrofluid, an injectable, biologically active cartilage repair product for arthroscopic treatment of chondral defects in the knee. The key objectives included validating Chondrofluid's use in an in vivo preclinical minipig model to treat partial-thickness and full-thickness cartilage defects. In 2021, Cartilage Inc. was awarded a $256,000 Project Grant from the National Science Foundation Division of Industrial Innovation to develop a biological adhesive for the fixation and integration of cartilage implants. Additionally, in 2020, the company received a $252,131 Project Grant from NIAMS to evaluate the pre-clinical safety and efficacy of Hyaleo, a product for healing large cartilage defects in the knee. These awards demonstrate Cartilage Inc.'s expertise in developing innovative cartilage repair solutions through federal grant programs aimed at fostering biomedical research and engineering innovation.

Quick answers

Is Cartilage Inc. registered in SAM.gov?

Yes. Cartilage Inc.'s SAM.gov registration is active through December 22, 2026.

What is Cartilage Inc.'s CAGE code?

Cartilage Inc.'s CAGE code is 89M68, and its Unique Entity ID (UEI) is C47HFKTMNMA4.

What is Cartilage Inc.'s most recent federal award?

Cartilage Inc.'s most recent federal grant award is Chondrofluid for arthroscopic knee cartilage repair (R41AR081741), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 21, 2023.

On GovTribe

See Cartilage Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe